KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks' Dec 8, 2025 07:11AM
KeyBanc on BioLife Solutions (BLFS): 'NDR Reveals Multiple Avenues to Reach LT Growth' Oct 3, 2025 07:57AM
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure' Sep 30, 2025 07:55AM
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure' Sep 30, 2025 07:55AM
KeyBanc on BioLife Solutions (BLFS): 'Bullish Outlook for BLFS with Sexton Portfolio' Mar 17, 2025 07:54AM


Jan 7, 2025 06:28AM KeyBanc Reiterates Overweight Rating on BioLife Solutions (BLFS) Following Tony Hunt's Appointment
Dec 13, 2024 08:15AM BioLife Solutions (BLFS) PT Raised to $33 at KeyBanc, Citing 'Tantalizing Growth Potential of +25%'
Mar 1, 2022 08:05AM BioLife Solutions to Attend and Present at Upcoming Investor Conferences
May 5, 2021 12:23PM BioLife Solutions (BLFS) Defended at KeyBanc
Oct 15, 2020 07:35AM Companies with NDRs 10/15